Published in Immunol Allergy Clin North Am on October 28, 2013
Vibratory Urticaria Associated with a Missense Variant in ADGRE2. N Engl J Med (2016) 2.09
The association of cholinergic and cold-induced urticaria: diagnosis and management. BMJ Case Rep (2015) 0.84
Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations. Allergy Asthma Immunol Res (2017) 0.78
Dissociation between history and challenge in patients with physical urticaria. J Allergy Clin Immunol Pract (2014) 0.78
Dermographism in the Oral Cavity. Am J Case Rep (2016) 0.75
Brain-derived neurotrophic factor is increased in serum levels of patients with symptomatic dermographism. Postepy Dermatol Alergol (2017) 0.75
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol (2010) 5.80
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med (2010) 2.98
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol (2011) 2.29
IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat Med (2007) 2.00
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol (2009) 1.98
WAO Guideline for the Management of Hereditary Angioedema. World Allergy Organ J (2012) 1.96
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol (2013) 1.91
Acupuncture in patients with seasonal allergic rhinitis: a randomized trial. Ann Intern Med (2013) 1.76
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy (2009) 1.65
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol (2011) 1.64
Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria. J Allergy Clin Immunol (2009) 1.60
Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ J (2012) 1.58
Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). J Invest Dermatol (2007) 1.54
Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol (2006) 1.53
IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J Immunol (2010) 1.52
A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J (2013) 1.51
Desloratadine inhibits human skin mast cell activation and histamine release. J Invest Dermatol (2009) 1.51
Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria. J Allergy Clin Immunol (2004) 1.51
Mast cells are required for normal healing of skin wounds in mice. FASEB J (2006) 1.50
Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. Hypertension (2010) 1.50
Effects of a pseudoallergen-free diet on chronic spontaneous urticaria: a prospective trial. Allergy (2009) 1.49
Mast cells--key effector cells in immune responses. Trends Immunol (2007) 1.48
T cell killing by tolerogenic dendritic cells protects mice from allergy. J Clin Invest (2011) 1.41
TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood (2005) 1.39
Migration of melanoblasts into the developing murine hair follicle is accompanied by transient c-Kit expression. J Histochem Cytochem (2002) 1.26
1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol (2008) 1.25
International consensus on hereditary and acquired angioedema. Ann Allergy Asthma Immunol (2012) 1.17
Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis. Eur J Immunol (2005) 1.16
Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol (2009) 1.16
Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol (2010) 1.15
Physical urticaria. Curr Allergy Asthma Rep (2012) 1.14
IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria? PLoS One (2011) 1.10
Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. Am J Pathol (2007) 1.10
Redefinition of the human mast cell transcriptome by deep-CAGE sequencing. Blood (2014) 1.09
Immediate contact skin reactions, an update of Contact Urticaria, Contact Urticaria Syndrome and Protein Contact Dermatitis -- "A Never Ending Story". Eur J Dermatol (2010) 1.09
Frequency of atopic dermatitis and relevance of food allergy in adults in Germany. Acta Derm Venereol (2006) 1.09
Urticaria: current opinions about etiology, diagnosis and therapy. Acta Derm Venereol (2007) 1.07
Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe. Allergy Asthma Clin Immunol (2013) 1.05
Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokines. Proc Natl Acad Sci U S A (2012) 1.05
Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function. Eur J Immunol (2011) 1.04
Consensus statement on the management of urticaria. Indian J Dermatol (2011) 1.04
Omalizumab in chronic urticaria. Curr Opin Allergy Clin Immunol (2012) 1.03
Sub-lingual immunotherapy: world allergy organization position paper 2009. World Allergy Organ J (2009) 1.03
Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp Dermatol (2009) 1.02
Density-equalizing mapping and scientometric benchmarking of European allergy research. J Occup Med Toxicol (2010) 1.01
Mast cell functions in the innate skin immune system. Immunobiology (2007) 1.01
Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial. J Allergy Clin Immunol (2010) 1.00
Innate immunity and allergy in the skin. Curr Opin Immunol (2009) 1.00
Mast cells: makers and breakers of allergic inflammation. Curr Opin Allergy Clin Immunol (2009) 1.00
Kit is expressed by epithelial cells in vivo. J Invest Dermatol (2003) 0.98
Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab. J Allergy Clin Immunol (2010) 0.97
Mast cell-driven skin inflammation is impaired in the absence of sensory nerves. J Allergy Clin Immunol (2007) 0.96
Inflammatory murine skin responses to UV-B light are partially dependent on endothelin-1 and mast cells. Am J Pathol (2006) 0.96
Mast cell lines HMC-1 and LAD2 in comparison with mature human skin mast cells--drastically reduced levels of tryptase and chymase in mast cell lines. Exp Dermatol (2010) 0.95
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study. J Invest Dermatol (2014) 0.94
Update on chronic urticaria: focusing on mechanisms. Curr Opin Allergy Clin Immunol (2008) 0.93
The role of interleukin-1 in allergy-related disorders. Curr Opin Allergy Clin Immunol (2012) 0.93
Hereditary angioedema caused by c1-esterase inhibitor deficiency: a literature-based analysis and clinical commentary on prophylaxis treatment strategies. World Allergy Organ J (2011) 0.93
Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. J Allergy Clin Immunol (2012) 0.93
Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule. J Clin Oncol (2002) 0.93
Treatment of atopic dermatitis with pimecrolimus - impact on quality of life. Ther Clin Risk Manag (2007) 0.92
Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol (2011) 0.91
Chronic spontaneous urticaria in children: itching for insight. Pediatr Allergy Immunol (2011) 0.90
High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria. Acta Derm Venereol (2011) 0.90
Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema. Allergy Asthma Proc (2016) 0.90
Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol (2010) 0.89
Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN study. Int Arch Allergy Immunol (2010) 0.88
Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol (2012) 0.88
Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Allergy (2011) 0.88
Allergic rhinitis and asthma: a large cross-sectional study in the United Arab Emirates. Int Arch Allergy Immunol (2010) 0.88
Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells. Exp Dermatol (2008) 0.88
Randomized controlled trial of desloratadine for persistent allergic rhinitis: correlations between symptom improvement and quality of life. Allergy Asthma Proc (2013) 0.87
Skin testing with food allergens. Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), the Physicians' Association of German Allergologists (ADA) and the Society of Pediatric Allergology (GPA) together with the Swiss Society of Allergology. J Dtsch Dermatol Ges (2008) 0.87
Successful treatment of delayed pressure urticaria with anti-TNF-alpha. J Allergy Clin Immunol (2007) 0.87
Exogenous histamine aggravates eczema in a subgroup of patients with atopic dermatitis. Acta Derm Venereol (2009) 0.86
Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review. Curr Med Res Opin (2011) 0.86
Role of adverse reactions to food in urticaria and exercise-induced anaphylaxis. Int Arch Allergy Immunol (2002) 0.86
Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major/HIV co-infection in Cameroon: results of a large cross-sectional study. Trans R Soc Trop Med Hyg (2012) 0.86
The majority of brain mast cells in B10.PL mice is present in the hippocampal formation. Neurosci Lett (2005) 0.85
NMR solution structure and dynamics of the peptidyl-prolyl cis-trans isomerase domain of the trigger factor from Mycoplasma genitalium compared to FK506-binding protein. J Mol Biol (2002) 0.84
Baseline and stimulated turnover of cell surface c-Kit expression in different types of human mast cells. Exp Dermatol (2006) 0.84
Successful treatment of cutaneous mastocytosis and Ménière disease with anti-IgE therapy. J Allergy Clin Immunol (2007) 0.84
Human mast cells in the neurohormonal network: expression of POMC, detection of precursor proteases, and evidence for IgE-dependent secretion of alpha-MSH. J Invest Dermatol (2006) 0.84
The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article. J Allergy Clin Immunol (2010) 0.84
Role and relevance of mast cells in fungal infections. Front Immunol (2012) 0.84
Diagnostic approach for suspected pseudoallergic reaction to food ingredients. J Dtsch Dermatol Ges (2008) 0.84